These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3486193)

  • 1. Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms.
    Guy-Grand D; Vassalli P
    J Clin Invest; 1986 May; 77(5):1584-95. PubMed ID: 3486193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M; Sharrow SO; Shearer GM
    J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GVHR elicited by products of class I or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy.
    Piguet PF
    J Immunol; 1985 Sep; 135(3):1637-43. PubMed ID: 2410497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of intestinal graft-versus-host reactions across mutant major histocompatibility antigens by T lymphocyte subsets in mice.
    Mowat AM; Sprent J
    Transplantation; 1989 May; 47(5):857-63. PubMed ID: 2655224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-host reaction-induced immune modulation. I. Donor-recipient genetic disparity and the differential expression of Lyt-2, L3T4, and Ly-6 during acute reactions in the host thymus.
    Levy RB; Cotterell AH; Jones M; Malek TR
    J Immunol; 1988 Mar; 140(6):1717-25. PubMed ID: 3257983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal lesions of the GVHR: evaluation of the role of different MHC and non MHC loci and of the Ly-2+ and L3T4+ T lymphocytes.
    Piguet PF; Janin-Mercier A; Vassalli P; Saurat JH
    J Immunol; 1987 Jul; 139(2):406-10. PubMed ID: 2955041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reactions in the small intestine. VII. Induction of the intestinal phase of murine graft-versus-host-reaction by Lyt 2- T cells activated by I-A alloantigens.
    Mowat AM; Borland A; Parrott DM
    Transplantation; 1986 Feb; 41(2):192-8. PubMed ID: 3484848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. II. Immunohistochemical studies on the thyroiditis lesion.
    Sugihara S; Maruo S; Tada T; Tsujimura T; Kohno Y; Hamaoka T; Fujiwara H
    Reg Immunol; 1989; 2(6):345-54. PubMed ID: 2485683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    Korngold R; Sprent J
    J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
    Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
    Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells.
    Vidal K; Samarut C; Magaud JP; Revillard JP; Kaiserlian D
    J Immunol; 1993 Nov; 151(9):4642-50. PubMed ID: 8409425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic studies on the hepatic lesions induced by graft-versus-host reaction in MHC class II disparate hosts compared with primary biliary cirrhosis.
    Saitoh T; Fujiwara M; Nomoto M; Kamimura T; Ishihara K; Asakura H
    Am J Pathol; 1989 Aug; 135(2):301-7. PubMed ID: 2782375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. Role of class I and class II major histocompatibility complex.
    Sheng-Tanner XF; Miller RG
    Transplantation; 1994 Apr; 57(7):1081-7. PubMed ID: 8165707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease.
    Aizawa S; Kamisaku H; Sado T
    Bone Marrow Transplant; 1995 Oct; 16(4):603-9. PubMed ID: 8528179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.
    Ikarashi Y; Kawai K; Watanabe H; Matsumoto Y; Omata S; Fujiwara M
    Immunology; 1993 May; 79(1):95-102. PubMed ID: 8099568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
    Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
    J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
    Halle-Pannenko O; Pritchard LL; Rappaport H
    Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L3T4+ T cells induce hepatic lesions resembling primary biliary cirrhosis in mice with graft-versus-host reactions due to major histocompatibility complex class II disparity.
    Saitoh T; Fujiwara M; Asakura H
    Clin Immunol Immunopathol; 1991 Jun; 59(3):449-61. PubMed ID: 2029796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of in-vivo administration of a monoclonal antibody specific for the interleukin-2 receptor on the acute graft-versus-host reaction in mice.
    Volk HD; Brocke S; Osawa H; Diamantstein T
    Clin Exp Immunol; 1986 Oct; 66(1):126-31. PubMed ID: 3100116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.